期刊文献+

老年非霍奇金氏淋巴瘤伴肺栓塞患者的药学监护 被引量:1

Pharmaceutical Care for an Elderly Patient with Non-Hodgkin's Lymphoma Associated with Pulmonary Embolism
下载PDF
导出
摘要 目的通过临床药师对一例老年非霍奇金氏淋巴瘤伴肺栓塞患者的药学监护,探讨临床药师如何参与肿瘤患者血栓的预防和治疗。方法对一例肿瘤伴肺栓塞的患者实施全程药学监护,包括协助医师为患者制定抗凝与化疗方案,分析患者国际化标准比值异常波动的可能原因并调整华法林剂量,对患者长期抗凝治疗提供用药教育。结果在临床药师的配合下,医师为患者制定了个体化抗凝和抗肿瘤方案,保证其治疗的有效性和安全性。结论临床药师积极参与肿瘤患者的血栓管理,有利于患者的治疗与预后。 Objective To explore how clinical pharmacists participate in the prevention and treatment of thrombosis for cancer patients by providing full term pharmaceutical care for a patient with non-Hodgkin’s lymphoma associated with pulmonary embolism. Methods Clinical pharmacists participated in the treatment, including the development of anticoagulation therapy and chemotherapy, analysis of possible reasons for the abnormal fluctuation of INR and provision of medical education for the long-term anticoagulation treatment. Results With the help of clinical pharmacists, doctors made individualized anticoagulation and chemotherapy plan to ensure the effectiveness and safety of treatment. Conclusion Clinical pharmacists’ participation in the management of thrombosis of cancer patients is beneficial to the treatment and prognosis of patients.
作者 成舒乔 张赞玲 李湘平 尹桃 CHENG Shuqiao;ZHANG Zanling;LI Xiangping;YIN Tao(Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, China)
出处 《肿瘤药学》 CAS 2019年第2期325-328,333,共5页 Anti-Tumor Pharmacy
关键词 淋巴瘤 肺栓塞 药学监护 Lymphoma Pulmonary embolism Pharmaceutical care
  • 相关文献

参考文献4

二级参考文献73

  • 1赵永强.我国静脉血栓栓塞症的研究现状[J].中华内科杂志,2005,44(2):83-84. 被引量:39
  • 2Korl AD, le Gessie S, Snijder S, et al. Primary extranodal non- Hodgkin' s lymphoma (NHL): the impact of alternative defini- tions tested in the Comprehensive Cancer Centre West popula- tion-based NHL registry. Ann Oncol, 2003, 14:131-139.
  • 3Li XQ, Li GD, Gao ZF, et al. The relative frequencies of lympho- ma subtypes in China: a nationwide study of 10002 cases by the Chinese Lymphoma Study Group. Ann Oncol, 2011, 22 Suppl 4: ivl41.
  • 4Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a stan- dard regimen (CHOP) with three intensive chemotherapy regi- mens for advanced non-Hodgkin' s lymphoma. N Engl J Med, 1993, 328:1002-1006.
  • 5Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med, 2005, 352:1197-1205.
  • 6Coiffier B, Thieblemont C, Van Den Neste E,et ah Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemother- apy in DLBCL patients: a study by the Grouped' Etudes des Lymphomes de 1' Adulte. Blood, 2010, 116:2040-2045.
  • 7Seki R, Ohshima K, Nagafuji K, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol, 2010, 9 I: 258-266.
  • 8Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 2005, 23:5027-5033.
  • 9Habermama TM, Weller EA, Morrison VA, et al. Rituximab- CHOP versus CHOP alone or with maintenance rituximab in old- er patients with diffuse large B-cell lymphoma. J Clin Oncol, 2006, 24:3121-3127.
  • 10Tilly H, Dreyling M. ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin' s lymphoma: ESMO clinical recom- mendations for diagnosis, treatment and follow-up. Ann Oncol, 2008, Suppl 2:ii67-69.

共引文献440

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部